The groundbreaking success of Viagra undeniably reshaped the drug landscape, but betting in companies heavily reliant on off-patent versions presents a complex picture. Although early profits were substantial, the cessation of patents and the emergence of cheaper alternatives have diminished the customer base. Consequently, a thorough evaluation of